How to buy Eloxx Pharmaceuticals stock | $2.94

Eloxx Pharmaceuticals, Inc is a biotechnology business based in the US. Eloxx Pharmaceuticals shares (ELOX) are listed on the NASDAQ and all prices are listed in US Dollars. Eloxx Pharmaceuticals employs 29 staff and has a market cap (total outstanding shares value) of USD$172.3 million.

How to buy shares in Eloxx Pharmaceuticals

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Eloxx Pharmaceuticals. Find the stock by name or ticker symbol: ELOX. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Eloxx Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$2.94, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Eloxx Pharmaceuticals, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Eloxx Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Eloxx Pharmaceuticals share price

Use our graph to track the performance of ELOX stocks over time.

Eloxx Pharmaceuticals shares at a glance

• Key figures

Information last updated 2020-12-27.

Latest market close	USD$2.94
52-week range	USD$1.44 - USD$8.1614
50-day moving average	USD$3.1438
200-day moving average	USD$3.0112
Wall St. target price	USD$5
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.447

Buy Eloxx Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Eloxx Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Eloxx Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Eloxx Pharmaceuticals price performance over time

Historical closes compared with the close of $2.94 from 2020-12-09

1 week (2021-01-15)	-28.81%
1 month (2020-12-23)	-34.38%
3 months (2020-10-22)	-2.97%
6 months (2020-07-22)	-2.00%

1 year (2020-01-22)	-37.04%
2 years (2019-01-22)	-72.29%
3 years (2018-01-22)	8.6
5 years (2016-01-22)	1,052.94%

Eloxx Pharmaceuticals financials

Gross profit TTM	USD$0
Return on assets TTM	-43.49%
Return on equity TTM	-132.93%
Profit margin	0%
Book value	$0.376
Market capitalisation	USD$172.3 million

TTM: trailing 12 months

Shorting Eloxx Pharmaceuticals shares

There are currently 1.4 million Eloxx Pharmaceuticals shares held short by investors – that's known as Eloxx Pharmaceuticals's "short interest". This figure is 0.2% down from 1.4 million last month.

There are a few different ways that this level of interest in shorting Eloxx Pharmaceuticals shares can be evaluated.

Eloxx Pharmaceuticals's "short interest ratio" (SIR)

Eloxx Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Eloxx Pharmaceuticals shares currently shorted divided by the average quantity of Eloxx Pharmaceuticals shares traded daily (recently around 35061.088082902). Eloxx Pharmaceuticals's SIR currently stands at 38.6. In other words for every 100,000 Eloxx Pharmaceuticals shares traded daily on the market, roughly 38600 shares are currently held short.

However Eloxx Pharmaceuticals's short interest can also be evaluated against the total number of Eloxx Pharmaceuticals shares, or, against the total number of tradable Eloxx Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eloxx Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Eloxx Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0479% of the tradable shares (for every 100,000 tradable Eloxx Pharmaceuticals shares, roughly 48 shares are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Eloxx Pharmaceuticals.

Find out more about how you can short Eloxx Pharmaceuticals stock.

Eloxx Pharmaceuticals share dividends

We're not expecting Eloxx Pharmaceuticals to pay a dividend over the next 12 months.

Have Eloxx Pharmaceuticals's shares ever split?

Eloxx Pharmaceuticals's shares were split on a 1:20 basis on 20 December 2017. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Eloxx Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Eloxx Pharmaceuticals shares which in turn could have impacted Eloxx Pharmaceuticals's share price.

Eloxx Pharmaceuticals share price volatility

Over the last 12 months, Eloxx Pharmaceuticals's shares have ranged in value from as little as $1.44 up to $8.1614. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eloxx Pharmaceuticals's is 2.4018. This would suggest that Eloxx Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Eloxx Pharmaceuticals overview

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.

Frequently asked questions

• What percentage of Eloxx Pharmaceuticals is owned by insiders or institutions?

  Currently 11.163% of Eloxx Pharmaceuticals shares are held by insiders and 52.324% by institutions.

• How many people work for Eloxx Pharmaceuticals?

  Latest data suggests 29 work at Eloxx Pharmaceuticals.

• When does the fiscal year end for Eloxx Pharmaceuticals?

  Eloxx Pharmaceuticals's fiscal year ends in December.

• Where is Eloxx Pharmaceuticals based?

  Eloxx Pharmaceuticals's address is: 950 Winter Street, Waltham, MA, United States, 02451

• What is Eloxx Pharmaceuticals's ISIN number?

  Eloxx Pharmaceuticals's international securities identification number is: US29014R1032

• What is Eloxx Pharmaceuticals's CUSIP number?

  Eloxx Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 29014R103